Loading…
Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay
Purpose To evaluate O6-methyl guanine methyltransferase ( MGMT ) promoter methylation status in high grade glioma patients and to identify the best cutoff point as well as the most predictive CpG loci for patients survival. Method Consecutive high grade glioma patients treated with surgical gross to...
Saved in:
Published in: | Journal of neuro-oncology 2023-08, Vol.164 (1), p.171-177 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
To evaluate O6-methyl guanine methyltransferase (
MGMT
) promoter methylation status in high grade glioma patients and to identify the best cutoff point as well as the most predictive CpG loci for patients survival.
Method
Consecutive high grade glioma patients treated with surgical gross total resection followed by concomitant radiochemotherapy and adjuvant chemotherapy were included in this retrospective observational study. Methylation status of
MGMT
promoter CpG island of resected tumor tissue were evaluated using next generation sequencing assay. The outcomes were grouped as CpG 70–78, CpG 79–83, CpG 84–87, CpG 70–87, and whole promoter. Quantitative analyses were dichotomized as methylated or unmethylated based on the cutoff points set to %10, and methylation was further graded as |
---|---|
ISSN: | 0167-594X 1573-7373 |
DOI: | 10.1007/s11060-023-04397-1 |